Stephen A. Harrison

1.8k total citations · 1 hit paper
10 papers, 67 citations indexed

About

Stephen A. Harrison is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Stephen A. Harrison has authored 10 papers receiving a total of 67 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Hepatology. Recurrent topics in Stephen A. Harrison's work include Liver Disease Diagnosis and Treatment (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Stephen A. Harrison is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Stephen A. Harrison collaborates with scholars based in United States, United Kingdom and Netherlands. Stephen A. Harrison's co-authors include Naim Alkhouri, Rohit Loomba, Michael Charlton, Mary E. Rinella, Arun J. Sanyal, Meena B. Bansal, Mazen Noureddin, Madhavi Rudraraju, Raj Vuppalanchi and Edward Mena and has published in prestigious journals such as Journal of Hepatology, Clinical Pharmacokinetics and Clinical Gastroenterology and Hepatology.

In The Last Decade

Stephen A. Harrison

8 papers receiving 66 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis

2024 55 citations Mazen Noureddin, Michael Charlton et al. Clinical Gastroenterology and Hepatology profile →

Peers

Stephen A. Harrison

EPIDE

EDM

HEPAT

PHYSI

SURGE

Serena Pelusi Italy

Wayne Eskridge United States

Kenzo Motohashi United Kingdom

Isabel Correia Brazil

Mazen Noureddin United States

Stephanie DeVore United States

Monika Augustyn Poland

Sherlot Juan Song Hong Kong

Dalia Morales Arráez Spain

Nathalie de Préville France

Serena Pelusi Italy

Stephen A. Harrison

59 ×1.1

EPIDE

23 ×0.8

EDM

20 ×1.0

HEPAT

15 ×1.0

PHYSI

8 ×1.0

SURGE

Citations per year, relative to Stephen A. Harrison Stephen A. Harrison (= 1×) peers Serena Pelusi

Countries citing papers authored by Stephen A. Harrison

Since Specialization

Citations

This map shows the geographic impact of Stephen A. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Harrison more than expected).

Fields of papers citing papers by Stephen A. Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Harrison. The network helps show where Stephen A. Harrison may publish in the future.

Co-authorship network of co-authors of Stephen A. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Harrison. A scholar is included among the top collaborators of Stephen A. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Harrison. Stephen A. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Harrison, Stephen A., Naim Alkhouri, Grisell Ortiz‐Lasanta, et al.. (2025). A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH. Journal of Hepatology. 83(2). 293–303. 4 indexed citations

Alkhouri, Naim, Raj Vuppalanchi, Mazen Noureddin, et al.. (2025). LBO-006 Belapectin at 2 mg/kg/LBWreduces varices development in MASH cirrhosis with portal hypertension: results from the NAVIGATE trial. Journal of Hepatology. 82. S12–S13.

Noureddin, Mazen, Naim Alkhouri, Vlad Ratziu, et al.. (2024). WED-223 Clinical and biological predictors of liver fat content ≥8% as assessed by MRI-PDFF: combined data from multiple therapeutic trials including more than 10, 000 patients. Journal of Hepatology. 80. S518–S518.

Noureddin, Mazen, Michael Charlton, Stephen A. Harrison, et al.. (2024). Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis. Clinical Gastroenterology and Hepatology. 22(12). 2367–2377. 55 indexed citations breakdown →

Harrison, Stephen A., Julie Dubourg, Mazen Noureddin, et al.. (2024). OS-051 Association between advanced fibrosis and NASH-CRN activity score (NAS) components: combined data from multiple therapeutic trials including more than 10, 000 patients. Journal of Hepatology. 80. S37–S37. 1 indexed citations

Loomba, Rohit, Eduardo B. Martins, Katharine Grimmer, et al.. (2024). GS-011 Denifanstat, a fatty acid synthase (FASN) inhibitor, shows significant fibrosis improvement and MASH resolution in FASCINATE-2, a Ph2b 52 week international, randomized, double blind, placebo-controlled trial in patients with F2 or F3 fibrosis. Journal of Hepatology. 80. S4–S4. 2 indexed citations

Harrison, Stephen A., et al.. (2024). SAT-227 Evaluation of efficacy of Berberine Ursodeoxycholate (HTD1801) compared to ongoing use of GLP-1 receptor agonists in patients with MASH and T2DM. Journal of Hepatology. 80. S614–S615. 1 indexed citations

Noureddin, Mazen, et al.. (2024). THU-242 Comparison ofmachine learning model (MASML), VCTE, and FIB-4 scores for predicting the presence of MASLD in a large cohort of patients in the U.S. using the NHANES database. Journal of Hepatology. 80. S579–S579. 1 indexed citations

Alexander, Elizabeth, Stephen A. Harrison, Marjan Hezareh, et al.. (2023). Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers. Clinical Pharmacokinetics. 63(1). 57–68. 2 indexed citations

10.

Austin, Daren, Jennifer E. Sager, Elizabeth Alexander, et al.. (2022). Safety and Pharmacokinetics of the Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Administered by Intravenous Injection in Japanese and Caucasian Healthy Volunteers. Kansenshogaku zasshi. 96(2). 39–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact